Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559M Sell
5,223,760
-742,054
-12% -$81.6M 0.13% 137
2026
Q1
$627M Buy
5,965,814
+2,550,178
+75% +$300M 0.17% 112
2025
Q4
$426M Sell
3,415,636
-885,458
-21% -$105M 0.12% 176
2025
Q3
$508M Sell
4,301,094
-721,910
-14% -$76.2M 0.16% 111
2025
Q2
$475M Sell
5,023,004
-2,956,260
-37% -$270M 0.16% 120
2025
Q1
$689M Buy
7,979,264
+843,806
+12% +$83M 0.25% 86
2024
Q4
$660M Buy
7,135,458
+2,192
+0% +$211K 0.23% 95
2024
Q3
$637M Buy
7,133,266
+138,042
+2% +$11.6M 0.23% 99
2024
Q2
$513M Sell
6,995,224
-2,647,200
-27% -$211M 0.2% 116
2024
Q1
$744M Sell
9,642,424
-634,287
-6% -$48.5M 0.32% 72
2023
Q4
$710M Sell
10,276,711
-189,049
-2% -$11.4M 0.32% 68
2023
Q3
$602M Buy
10,465,760
+9,394,289
+877% +$534M 0.3% 77
2023
Q2
$59.9M Buy
1,071,471
+1,007,571
+1,577% +$50.3M 0.03% 474
2023
Q1
$3.01M Buy
+63,900
New +$3.03M ﹤0.01% 1086

Other funds holding CRH

Amundi's CRH Position: Q2 2026 in Review

Amundi reduced its CRH (CRH) stake by 12% in Q2 2026, selling an estimated $81.6M and leaving 5,223,760 shares worth $559M. The position accounts for 0.13% of the portfolio, ranked #137.

Amundi first reported a position in CRH in Q1 2023 and has held it in 14 quarters since. The position peaked at $744M in Q1 2024. 1,030 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Amundi held 5,223,760 shares of CRH worth $559M as of Q2 2026.
  • Amundi sold 742,054 CRH shares in Q2 2026, an estimated $81.6M.
  • CRH made up 0.13% of Amundi's portfolio in Q2 2026, its #137 holding.
  • Amundi first reported a position in CRH in Q1 2023 and has held it in 14 quarters since.
  • Amundi's CRH position peaked at $744M in Q1 2024.
  • 1,030 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.